Randomized controlled trial (RCT) to evaluate the effectiveness of applying Purell® (62% ethyl alcohol in emollient gel) to the penis of male partners of women diagnosed with BV for preventing BV recurrence after treatment.

The male partner in each couple was asked to apply Purell® to his penis at least daily, and immediately prior to and following intercourse. Couples received a brochure with information on control of STI and good hygienic practices. Brochures for intervention and control arms were similar except the intervention arm brochure provided information on how to use the study product (Purell®).

Other Name: Purell® (GOJO Healthcare Inc., Akron, OH)

Active Comparator: 2

Other: hygienic information

Couples received a brochure with information on control of STI and good hygienic practices.

Eligibility

Ages Eligible for Study:

18 Years and older

Genders Eligible for Study:

Both

Accepts Healthy Volunteers:

No

Criteria

Inclusion criteria:

Vaginal symptoms

Nugent score > 6 for vaginal fluid gram stain

Woman and her male partner both interested in study participation

Woman able to return for follow-up visits

Woman able to provide detailed contact information for tracing

Exclusion Criteria:

Either male or female partner not recruited within 24 hours of the other

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00542074